Related Experiment Video

Updated: Jan 8, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.1K

Anti-diabetic medications and cancer: links beyond glycemic and body weight control

Meng Cao1, Chu Lin1, Xiaoling Cai1

  • 1Department of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Center, Beijing 100044, China.

Precision Clinical Medicine
|December 12, 2025
PubMed

Insights

Anti-diabetic drugs may influence cancer risk beyond blood sugar and weight control. This review explores mechanisms like cell proliferation, hormones, and inflammation, offering insights for future research on diabetes and cancer.

Area of Science:

  • Endocrinology
  • Oncology
  • Pharmacology

Background:

  • Cancer is a leading cause of death in diabetic patients.
  • Hyperglycemia and obesity in type 2 diabetes increase cancer risk.
  • Current anti-diabetic treatments may not sufficiently mitigate cancer risk.

Purpose of the Study:

  • To review preclinical and clinical evidence on anti-diabetic drugs and cancer.
  • To explore mechanisms linking anti-diabetic medications to cancer beyond glycemic and weight control.
  • To provide insights for future research on the diabetes-cancer association.

Main Methods:

  • Literature review of preclinical and clinical studies.
  • Focus on anti-diabetic medications and their association with cancer.
  • Analysis of mechanisms beyond glycemic and body weight control.

Main Results:

  • Summarized evidence on various anti-diabetic drugs and cancer.
  • Identified mechanisms including cell proliferation, hormone levels, inflammation, oxidative stress, autophagy, apoptosis, gut microbiota, angiogenesis, and epithelial-mesenchymal transition.
  • Highlighted the need for further investigation into these links.

Conclusions:

  • Anti-diabetic medications may affect cancer risk through pathways independent of glucose and weight management.
  • Understanding these mechanisms is crucial for optimizing cancer prevention in diabetic patients.
  • Further clinical and mechanistic studies are warranted to fully elucidate the relationship.
Keywords:
anti-diabetic medicationscancertype 2 diabetes

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.8K
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

26.4K

Related Concept Videos

Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
562
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
409
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
848
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
505
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.6K